GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai MicroPort MedBot (Group) Co Ltd (HKSE:02252) » Definitions » Intrinsic Value: Projected FCF

Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Intrinsic Value: Projected FCF : HK$0.00 (As of Jun. 04, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai MicroPort MedBot (Group) Co Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-06-04), Shanghai MicroPort MedBot (Group) Co's Intrinsic Value: Projected FCF is HK$0.00. The stock price of Shanghai MicroPort MedBot (Group) Co is HK$16.06. Therefore, Shanghai MicroPort MedBot (Group) Co's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Shanghai MicroPort MedBot (Group) Co's Intrinsic Value: Projected FCF or its related term are showing as below:

HKSE:02252's Price-to-Projected-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.53
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Shanghai MicroPort MedBot (Group) Co Intrinsic Value: Projected FCF Historical Data

The historical data trend for Shanghai MicroPort MedBot (Group) Co's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai MicroPort MedBot (Group) Co Intrinsic Value: Projected FCF Chart

Shanghai MicroPort MedBot (Group) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial - - - - -

Shanghai MicroPort MedBot (Group) Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Shanghai MicroPort MedBot (Group) Co's Intrinsic Value: Projected FCF

For the Medical Devices subindustry, Shanghai MicroPort MedBot (Group) Co's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai MicroPort MedBot (Group) Co's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai MicroPort MedBot (Group) Co's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai MicroPort MedBot (Group) Co's Price-to-Projected-FCF falls into.


;
;

Shanghai MicroPort MedBot (Group) Co Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Shanghai MicroPort MedBot (Group) Co  (HKSE:02252) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Shanghai MicroPort MedBot (Group) Co's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=16.06/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai MicroPort MedBot (Group) Co Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Shanghai MicroPort MedBot (Group) Co's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai MicroPort MedBot (Group) Co Business Description

Traded in Other Exchanges
N/A
Address
1601 Zhangdong Road, Room 101, Area B, Building 1, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN
Shanghai MicroPort MedBot (Group) Co Ltd is a surgical robot company dedicated to designing, developing, and commercializing surgical robots to assist surgeons in performing complex surgical procedures. Its business covers various surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice, and percutaneous surgical procedures, and has accumulated several products at various stages as those in development, clinical trials, registration, and commercialisation. The company derives revenue principally from the sales of surgical robot systems, instruments, and accessories, and the provision of services through appointed distributors. Geographically, it derives key revenue from the People's Republic of China, followed by Europe, Africa, Australia, and other regions.
Executives
He Chao 2201 Interest of corporation controlled by you
Ji Shufang 2202 Interest of your spouse
Shang Hai Qing Zhen Qi Ye Guan Li Zi Xun Zhong Xin You Xian He Huo 2103 Interests held jointly with another person
Wei Chuang Yi Liao Ke Xue You Xian Gong Si 2201 Interest of corporation controlled by you
Shang Hai Qing Min Qi Ye Guan Li Zi Xun Zhong Xin You Xian He Huo 2101 Beneficial owner
Wei Chuang Tou Zi Kong Gu You Xian Gong Si 2201 Interest of corporation controlled by you
Yuan Shuai 2201 Interest of corporation controlled by you
Wu Kaili 2202 Interest of your spouse
Shenzhen Gao Ling Tiancheng Phase Iii Investment Co., Ltd. 2201 Interest of corporation controlled by you
Shenzhen Gao Ling Muqi Equity Investment Fund Llp 2201 Interest of corporation controlled by you
Xiamen Gao Ling Ruiqi Equity Investment Fund Llp 2201 Interest of corporation controlled by you
Zhuhai Gao Ling Chongheng Equity Investment Llp 2101 Beneficial owner
Shang Hai Wei Chuang Tou Zi Kong Gu You Xian Gong Si 2201 Interest of corporation controlled by you
Shang Hai Mo Hua Ren Gong Zhi Neng Ke Ji You Xian Gong Si 2103 Interests held jointly with another person

Shanghai MicroPort MedBot (Group) Co Headlines

No Headlines